Physician profile
Robert Lewis
NPI 1093737728
$21,286.88
in general payments reported to CMS, 2019-2025
16 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $1,098 · 2021: $6,346 · 2022: $4,179 · 2023: $5,457 · 2024: $2,595 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,600 · Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,600.00 |
| Food and Beverage | $2,190.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $15,416.29 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $3,460.85 | 2021-2025 | Endurant Iis, In.Pact Admiral, Hawkone |
| Medtronic Vascular, INC. | $713.35 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $480.36 | 2025 | Assure Wcd |
| Biotronik INC. | $268.91 | 2022 | |
| Cardinal Health 200 LLC | $207.59 | 2019 | |
| Cardiovascular Systems INC. | $199.26 | 2019 | |
| Boston Scientific Corporation | $131.08 | 2022-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $111.50 | 2024 | Esprit |
| Inari Medical, INC. | $101.13 | 2021 | |
| Imperative Care, INC | $78.55 | 2023 | Symphony Catheter |
| Cardiva Medical, INC. | $38.50 | 2023 | Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.69 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $19.03 | 2022 | |
| Cook Medical LLC | $18.02 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.